T cell Polarization toward T(H)2/T(FH)2 and T(H)17/T(FH)17 in Patients with IgG4-related Disease

Archive ouverte

Grados, Aurelie | Ebbo, Mikael | Piperoglou, Christelle | Groh, Matthieu | Régent, Alexis | Samson, Maxime | Terrier, Benjamin | Loundou, Anderson | Morel, Nathalie | Audia, Sylvain | Maurier, François | Graveleau, Julie | Hamidou, Mohamed | Forestier, Amandine | Palat, Sylvain | Bernit, Emmanuelle | Bonotte, Bernard | Farnarier, Catherine | Harlé, Jean-Robert | Costedoat-Chalumeau, Nathalie | Vely, Frederic | Schleinitz, Nicolas

Edité par CCSD ; Frontiers -

International audience. IgG4-related disease (IgG4-RD) is a fibro-inflammatory disorder involving virtually every organ with a risk of organ dysfunction. Despite recent studies regarding B cell and T cell compartments, the disease's pathophysiology remains poorly understood. We examined and characterized subsets of circulating lymphocytes in untreated patients with active IgG4-RD. Twenty-eight consecutive patients with biopsy-proven IgG4-RD were included in a prospective, multicentric study. Lymphocyte's subsets were analyzed by flow cytometry, with analysis of T(H)1/T(H)2/T(H)17, T-FH cells, and cytokine release by peripheral blood mononuclear cells. Results were compared to healthy controls and to patients with primary Sjogren's syndrome. Patients with IgG4-RD showed an increase of circulating T regulatory, T(H)2, T(H)17, and CD4(+)CXCR5(+)PD1(+) TFH cell subsets. Accordingly, increased levels of IL-10 and IL-4 were measured in IgG-RD patients. TFH increase was characterized by the specific expansion of T(FH)2 (CCR6(-)CXCR3(-)), and to a lesser extent of (T(FH)17 (CCR6(+)CXCR3(-))) cells. Interestingly, CD4(+)CXCR5(+)PD1(+) TFH cells normalized under treatment. IgG4-RD is characterized by a shift of circulating T cells toward a T(H)2/T(FH)2 and T(H)17/T(FH)17 polarization. This immunological imbalance might be implicated in the disease's pathophysiology. Treatment regimens targeting such T cells warrant further evaluation.

Consulter en ligne

Suggestions

Du même auteur

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

Archive ouverte | Ebbo, Mikael | CCSD

International audience. Objectives: To assess efficacy and safety of rituximab (RTX) as induction therapy, maintenance of remission and treatment of relapses in a cohort of IgG4-related disease (IgG4-RD) patients.Me...

CIRCULATING INNATE LYMPHOID CELLS IN IGG4-RELATED DISEASE

Archive ouverte | Ebbo, Mikael | CCSD

Annual European Congress of Rheumatology (EULAR), Madrid, SPAIN, JUN 12-15, 2019. International audience

Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.

Archive ouverte | Ebbo, Mikael | CCSD

International audience

Chargement des enrichissements...